← Open Payments lookup

RACHEL SWEENEY: Open Payments

NPI 1265424055 · ARNOLD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$942 in 35 payments from 18 companies in 2025. Trend: 2023 $233 · 2024 $918 · 2025 $942

Food & beverage: $942
CompanyPaymentsAmount
Novo Nordisk Inc11$257
Madrigal Pharmaceuticals1$108
Medtronic, Inc.1$104
Exact Sciences Corporation3$77
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$51
ABBVIE INC.2$45
Boston Scientific Corporation1$45
Amgen Inc.2$40
Abbott Laboratories2$38
AstraZeneca Pharmaceuticals LP1$25

Products named: REZDIFFRA, Ozempic, SYMPLICITY G3, Wegovy, Rybelsus, The Cologuard Plus Collection Kit, XIFAXAN, WaveWriter Alpha Prime 16.

Industry payments across MD — which companies pay providers there.